Semax and selank on TikTok: separating hype from actual data

What did @pepmanchris actually say?

On day three of using semax and selank, the creator reported that semax delivers "a nice euphoric natural mood enhancer" with improved focus and mental clarity. He compared the feeling to "one of the most euphoric and best caffeinated feelings that you could get." He also mentioned a headache after his first night using selank, though he acknowledged it might be coincidental. These are anecdotal self-reports from a single person after 72 hours, and he is transparent enough to admit the experience is hard to put into words. That honesty is worth acknowledging, even if the broader framing has problems.

The core issue here is that he is describing subjective sensations, not outcomes, and conflating an early-stage neurological response with proof that the compounds are working as advertised. Three days is not enough time to draw conclusions about anything.

Does the science back this up?

Partially, but not in the way the video implies. Semax is a synthetic heptapeptide derived from ACTH(4-7) that has been studied in Russia for cognitive and neuroprotective purposes. There is real research here, but it is mostly preclinical or conducted on specific patient populations, not healthy recreational users chasing a mood lift.

Animal studies, including work by Dolotov et al. (2006, Neuroscience), show semax increases brain-derived neurotrophic factor (BDNF) and influences dopaminergic and serotonergic systems, which could plausibly explain a subjective mood or focus effect. Selank has been studied for anxiolytic effects, with Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) showing reduced anxiety markers in both animal models and small human trials. However, human trials for both peptides are limited, often underpowered, and largely originate from Russian research groups without independent replication in Western peer-reviewed literature. The euphoria framing oversells what the evidence actually supports.

What did they get wrong (or right)?

Let's give credit where it is due: the creator did not claim to be cured of anything, he disclosed his dose, and he was upfront that his selank experience was incomplete. That is more responsible than a lot of peptide content on TikTok.

What he got wrong is the certainty behind his language. Calling semax "fucking amazing" and comparing it to the best caffeinated feeling after three days is classic placebo territory. The expectation effect in nootropic self-experimentation is well documented. Beedie et al. (2006, Journal of Sports Sciences) showed robust placebo responses in performance and mood contexts, and that dynamic applies directly here.

• The "euphoric" descriptor is a red flag. Semax does not work on opioid receptors and should not produce true euphoria. What he is likely describing is a stimulant-adjacent alertness effect or a placebo response.
• His headache after selank is anecdotally reported by other users online, but there is no peer-reviewed explanation for it. Attributing it to the peptide without more data is speculative.
• Describing these compounds as simply "amino acids" in the hashtags is technically reductive and potentially misleading about their pharmacological complexity.

What should you actually know?

Semax and selank are not FDA-approved for any indication in the United States. They are not available as approved prescription drugs domestically, and any product sold for human use exists in a regulatory gray area. That matters for safety, not just legality.

Both peptides have a real research base, which is more than can be said for many nootropic compounds flooding social media. But "has been studied" is not the same as "proven safe and effective for healthy adults seeking cognitive enhancement." Most semax research focuses on stroke recovery, optic nerve disease, and ADHD-adjacent populations, not performance optimization in healthy individuals.

If you are drawn to this category, the honest conversation includes: sourcing and purity verification (there is no regulatory oversight of compounded peptides in this space), unknown long-term effects in healthy populations, and the very real possibility that what people experience early on is driven by expectation rather than pharmacology. A three-day self-report on TikTok is not clinical evidence, and it should not be treated as a product recommendation.